Clinical trials
Terminated Endometrial Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 2 |
| Blueprint Medicines Corporation | 1 |
| Genmab | 1 |
| Incyte Corporation | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| NuCana plc | 1 |
| Otsuka Novel Products GmbH | 1 |
| Pfizer | 1 |
| R-Pharm | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 13 |
| Ovarian Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Stomach Neoplasms | 4 |
| Neoplasm Metastasis | 3 |
| Uterine Cervical Neoplasms | 3 |
| Adenocarcinoma, Mucinous | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.